Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America

Rhea-AI Filing Summary

Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of Ordinary Shares of Drugs Made in America Acquisition Corp. As of 06/30/2026, they collectively report 999,899 shares, representing 4.12% of the class. All reported shares are held through funds and managed accounts for which Glazer Capital acts as investment manager.

The Reporting Persons state they have shared voting and dispositive power over 999,899 shares and no sole voting or dispositive power. They also indicate that their position represents ownership of 5 percent or less of the outstanding Ordinary Shares and include a disclaimer that the report should not be construed as an admission of beneficial ownership for certain legal purposes.

Key Figures

Beneficial ownership: 999,899 shares Percent of class: 4.12% Shared voting power: 999,899 shares +4 more

7 metrics

Beneficial ownership 999,899 shares Ordinary Shares of Drugs Made in America Acquisition Corp. beneficially owned as of 06/30/2026

Percent of class 4.12% Percentage of DMAA Ordinary Shares represented by the 999,899 shares

Shared voting power 999,899 shares Shares over which the Reporting Persons have shared power to vote or direct the vote

Shared dispositive power 999,899 shares Shares over which the Reporting Persons have shared power to dispose or direct disposition

Ownership threshold 5 percent or less Ownership of 5 percent or less of a class reported under Item 5

Event date 06/30/2026 Date associated with the reported ownership position

Signature date 08/13/2026 Date Paul J. Glazer signed as Managing Member and individual reporting person

Key Terms

beneficial owner, shared voting power, shared dispositive power, Schedule 13G/A, +1 more

5 terms

beneficial owner regulatory

"beneficial owner of the shares of Common Stock reported herein"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

shared voting power regulatory

"Shared Voting Power 999,899.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power regulatory

"Shared Dispositive Power 999,899.00"

Schedule 13G/A regulatory

"This statement is filed by the Reporting Persons on Schedule 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

percent of class financial

"Percent of class: 4.12%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What ownership in DMAA does Glazer Capital report in this Schedule 13G/A?

Glazer Capital and Paul J. Glazer report beneficial ownership of 999,899 Ordinary Shares of Drugs Made in America Acquisition Corp., representing 4.12% of the outstanding class as of 06/30/2026.

Does Glazer Capital control more than 5% of DMAA’s shares?

No. The Reporting Persons state their position represents 4.12% of DMAA’s Ordinary Shares and explicitly indicate ownership of 5 percent or less of the class, placing them below the 5% threshold.

How many DMAA shares does Glazer Capital have voting power over?

Glazer Capital and Paul J. Glazer report shared voting power over 999,899 Ordinary Shares and no sole voting power. The same 999,899 shares are also subject to shared dispositive power through the Glazer-managed funds.

Who are the reporting persons in the DMAA Schedule 13G/A amendment?

The reporting persons are Glazer Capital, LLC, a Delaware limited liability company, and Paul J. Glazer, a United States citizen and Managing Member of Glazer Capital, each reporting with respect to shares held by Glazer-managed funds.

Where are Glazer Capital and DMAA based according to this Schedule 13G/A?

Drugs Made in America Acquisition Corp. lists its principal executive offices at 420 Lexington Avenue, Suite 1402, New York, NY 10170, while the Reporting Persons’ business address is 250 West 55th Street, Suite 30A, New York, NY 10019.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 05:13 PM Accepted by SEC EDGAR 08/13/2026 - 05:12 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

DRUGS MADE IN AMERICA ACQUISITION CORP.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

G2847J104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G2847J104

1

Names of Reporting Persons

Glazer Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 999,899.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 999,899.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

999,899.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.12 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): G2847J104

1

Names of Reporting Persons

Paul J. Glazer

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 999,899.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 999,899.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

999,899.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.12 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: DRUGS MADE IN AMERICA ACQUISITION CORP.
(b)	Address of issuer's principal executive offices: 420 Lexington Avenue, Suite 1402, New York, NY 10170
Item 2.
(a)	Name of person filing: This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019.
(c)	Citizenship: Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen.
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP No.: G2847J104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 999,899
(b)	Percent of class: 4.12%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 999,899
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 999,899
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glazer Capital, LLC

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer, Managing Member
Date:	08/13/2026

Paul J. Glazer

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer
Date:	08/13/2026